世界の偽腫瘍セレブリ市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Pseudotumor Cerebri Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4854 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、133ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、偽腫瘍セレブリのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（眼底検査、ニューロ画像、腰椎穿刺）、用途別市場規模（髄液シャント、視神経鞘開窓、静脈洞ステント留置、投薬）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・偽腫瘍セレブリの市場動向 ・企業の競争状況、市場シェア ・偽腫瘍セレブリの種類別市場規模（眼底検査、ニューロ画像、腰椎穿刺） ・偽腫瘍セレブリの用途別市場規模（髄液シャント、視神経鞘開窓、静脈洞ステント留置、投薬） ・偽腫瘍セレブリの北米市場規模2016-2027（アメリカ、カナダ） ・偽腫瘍セレブリのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・偽腫瘍セレブリのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・偽腫瘍セレブリの中南米市場規模2016-2027（メキシコ、ブラジル） ・偽腫瘍セレブリの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Avkare, Inc.、B. Braun Melsungen AG、Beckersmith Medical, Inc.、Elekta AB、Heritage Pharmaceuticals Inc.、Ingenus Pharmaceuticals、Integra LifeSciences Corporation、Johnson & Johnson Services, Inc.、Lannett Company, Inc.、Magstim、Medtronic、MercuryPharma、Nostrum Laboratories Inc.、Novast Holdings Ltd.、Phoenix Biomedical Corp.、Sanofi, SGPharma Pvt. Ltd.、Sophysa、Taro Pharmaceutical Industries Ltd.、Teva Pharmaceutical Industries Ltd.、West-Ward Pharmaceutical、Zydus Pharmaceuticals, Inc.） ・結論

Pseudotumor Cerebri, also known as idiopathic intracranial hypertension (IIH) is a syndrome of elevated intracranial pressure (ICP) that occurs predominantly in obese women of childbearing age. Headaches and vision impairment are most commonly found in patients with Pseudotumor Cerebri. The visual symptoms may arise due to papilledema.
Asia Pacific is the fastest growing pseudotumor cerebri market owing to a huge patient pool and development in healthcare technology. Healthcare expenditure is found to be boosting in various regions of Asia Pacific.

Market Analysis and Insights: Global Pseudotumor Cerebri Market
The global Pseudotumor Cerebri market size is projected to reach US$ 12500 million by 2026, from US$ 8872 million in 2019, at a CAGR of 5.0% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pseudotumor Cerebri market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pseudotumor Cerebri market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pseudotumor Cerebri market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pseudotumor Cerebri market.

Global Pseudotumor Cerebri Scope and Market Size
Pseudotumor Cerebri market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pseudotumor Cerebri market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Fundoscopy
Neuroimaging
Lumbar Puncture

Segment by Application
Spinal Fluid Shunt
Optic Nerve Sheath Fenestration
Venous Sinus Stenting
Medication

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Avkare, Inc.
B. Braun Melsungen AG
Beckersmith Medical, Inc.
Elekta AB
Heritage Pharmaceuticals Inc.
Ingenus Pharmaceuticals
Integra LifeSciences Corporation
Johnson & Johnson Services, Inc.
Lannett Company, Inc.
Elekta AB
Heritage Pharmaceuticals Inc.
MercuryPharma
Nostrum Laboratories Inc.
Novast Holdings Ltd.
Phoenix Biomedical Corp.
Sanofi, SGPharma Pvt. Ltd.
Sophysa
Taro Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pseudotumor Cerebri Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Fundoscopy
1.2.3 Neuroimaging
1.2.4 Lumbar Puncture
1.3 Market by Application
1.3.1 Global Pseudotumor Cerebri Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Spinal Fluid Shunt
1.3.3 Optic Nerve Sheath Fenestration
1.3.4 Venous Sinus Stenting
1.3.5 Medication
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Pseudotumor Cerebri Market Perspective (2016-2027)
2.2 Pseudotumor Cerebri Growth Trends by Regions
2.2.1 Pseudotumor Cerebri Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pseudotumor Cerebri Historic Market Share by Regions (2016-2021)
2.2.3 Pseudotumor Cerebri Forecasted Market Size by Regions (2022-2027)
2.3 Pseudotumor Cerebri Industry Dynamic
2.3.1 Pseudotumor Cerebri Market Trends
2.3.2 Pseudotumor Cerebri Market Drivers
2.3.3 Pseudotumor Cerebri Market Challenges
2.3.4 Pseudotumor Cerebri Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Pseudotumor Cerebri Players by Revenue
3.1.1 Global Top Pseudotumor Cerebri Players by Revenue (2016-2021)
3.1.2 Global Pseudotumor Cerebri Revenue Market Share by Players (2016-2021)
3.2 Global Pseudotumor Cerebri Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pseudotumor Cerebri Revenue
3.4 Global Pseudotumor Cerebri Market Concentration Ratio
3.4.1 Global Pseudotumor Cerebri Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pseudotumor Cerebri Revenue in 2020
3.5 Pseudotumor Cerebri Key Players Head office and Area Served
3.6 Key Players Pseudotumor Cerebri Product Solution and Service
3.7 Date of Enter into Pseudotumor Cerebri Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Pseudotumor Cerebri Breakdown Data by Type
4.1 Global Pseudotumor Cerebri Historic Market Size by Type (2016-2021)
4.2 Global Pseudotumor Cerebri Forecasted Market Size by Type (2022-2027)

5 Pseudotumor Cerebri Breakdown Data by Application
5.1 Global Pseudotumor Cerebri Historic Market Size by Application (2016-2021)
5.2 Global Pseudotumor Cerebri Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Pseudotumor Cerebri Market Size (2016-2027)
6.2 North America Pseudotumor Cerebri Market Size by Type
6.2.1 North America Pseudotumor Cerebri Market Size by Type (2016-2021)
6.2.2 North America Pseudotumor Cerebri Market Size by Type (2022-2027)
6.2.3 North America Pseudotumor Cerebri Market Size by Type (2016-2027)
6.3 North America Pseudotumor Cerebri Market Size by Application
6.3.1 North America Pseudotumor Cerebri Market Size by Application (2016-2021)
6.3.2 North America Pseudotumor Cerebri Market Size by Application (2022-2027)
6.3.3 North America Pseudotumor Cerebri Market Size by Application (2016-2027)
6.4 North America Pseudotumor Cerebri Market Size by Country
6.4.1 North America Pseudotumor Cerebri Market Size by Country (2016-2021)
6.4.2 North America Pseudotumor Cerebri Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Pseudotumor Cerebri Market Size (2016-2027)
7.2 Europe Pseudotumor Cerebri Market Size by Type
7.2.1 Europe Pseudotumor Cerebri Market Size by Type (2016-2021)
7.2.2 Europe Pseudotumor Cerebri Market Size by Type (2022-2027)
7.2.3 Europe Pseudotumor Cerebri Market Size by Type (2016-2027)
7.3 Europe Pseudotumor Cerebri Market Size by Application
7.3.1 Europe Pseudotumor Cerebri Market Size by Application (2016-2021)
7.3.2 Europe Pseudotumor Cerebri Market Size by Application (2022-2027)
7.3.3 Europe Pseudotumor Cerebri Market Size by Application (2016-2027)
7.4 Europe Pseudotumor Cerebri Market Size by Country
7.4.1 Europe Pseudotumor Cerebri Market Size by Country (2016-2021)
7.4.2 Europe Pseudotumor Cerebri Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Pseudotumor Cerebri Market Size (2016-2027)
8.2 Asia-Pacific Pseudotumor Cerebri Market Size by Type
8.2.1 Asia-Pacific Pseudotumor Cerebri Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pseudotumor Cerebri Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pseudotumor Cerebri Market Size by Type (2016-2027)
8.3 Asia-Pacific Pseudotumor Cerebri Market Size by Application
8.3.1 Asia-Pacific Pseudotumor Cerebri Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pseudotumor Cerebri Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pseudotumor Cerebri Market Size by Application (2016-2027)
8.4 Asia-Pacific Pseudotumor Cerebri Market Size by Region
8.4.1 Asia-Pacific Pseudotumor Cerebri Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pseudotumor Cerebri Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Pseudotumor Cerebri Market Size (2016-2027)
9.2 Latin America Pseudotumor Cerebri Market Size by Type
9.2.1 Latin America Pseudotumor Cerebri Market Size by Type (2016-2021)
9.2.2 Latin America Pseudotumor Cerebri Market Size by Type (2022-2027)
9.2.3 Latin America Pseudotumor Cerebri Market Size by Type (2016-2027)
9.3 Latin America Pseudotumor Cerebri Market Size by Application
9.3.1 Latin America Pseudotumor Cerebri Market Size by Application (2016-2021)
9.3.2 Latin America Pseudotumor Cerebri Market Size by Application (2022-2027)
9.3.3 Latin America Pseudotumor Cerebri Market Size by Application (2016-2027)
9.4 Latin America Pseudotumor Cerebri Market Size by Country
9.4.1 Latin America Pseudotumor Cerebri Market Size by Country (2016-2021)
9.4.2 Latin America Pseudotumor Cerebri Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Pseudotumor Cerebri Market Size (2016-2027)
10.2 Middle East & Africa Pseudotumor Cerebri Market Size by Type
10.2.1 Middle East & Africa Pseudotumor Cerebri Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pseudotumor Cerebri Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pseudotumor Cerebri Market Size by Type (2016-2027)
10.3 Middle East & Africa Pseudotumor Cerebri Market Size by Application
10.3.1 Middle East & Africa Pseudotumor Cerebri Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pseudotumor Cerebri Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pseudotumor Cerebri Market Size by Application (2016-2027)
10.4 Middle East & Africa Pseudotumor Cerebri Market Size by Country
10.4.1 Middle East & Africa Pseudotumor Cerebri Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pseudotumor Cerebri Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Avkare, Inc.
11.1.1 Avkare, Inc. Company Details
11.1.2 Avkare, Inc. Business Overview
11.1.3 Avkare, Inc. Pseudotumor Cerebri Introduction
11.1.4 Avkare, Inc. Revenue in Pseudotumor Cerebri Business (2016-2021)
11.1.5 Avkare, Inc. Recent Development
11.2 B. Braun Melsungen AG
11.2.1 B. Braun Melsungen AG Company Details
11.2.2 B. Braun Melsungen AG Business Overview
11.2.3 B. Braun Melsungen AG Pseudotumor Cerebri Introduction
11.2.4 B. Braun Melsungen AG Revenue in Pseudotumor Cerebri Business (2016-2021)
11.2.5 B. Braun Melsungen AG Recent Development
11.3 Beckersmith Medical, Inc.
11.3.1 Beckersmith Medical, Inc. Company Details
11.3.2 Beckersmith Medical, Inc. Business Overview
11.3.3 Beckersmith Medical, Inc. Pseudotumor Cerebri Introduction
11.3.4 Beckersmith Medical, Inc. Revenue in Pseudotumor Cerebri Business (2016-2021)
11.3.5 Beckersmith Medical, Inc. Recent Development
11.4 Elekta AB
11.4.1 Elekta AB Company Details
11.4.2 Elekta AB Business Overview
11.4.3 Elekta AB Pseudotumor Cerebri Introduction
11.4.4 Elekta AB Revenue in Pseudotumor Cerebri Business (2016-2021)
11.4.5 Elekta AB Recent Development
11.5 Heritage Pharmaceuticals Inc.
11.5.1 Heritage Pharmaceuticals Inc. Company Details
11.5.2 Heritage Pharmaceuticals Inc. Business Overview
11.5.3 Heritage Pharmaceuticals Inc. Pseudotumor Cerebri Introduction
11.5.4 Heritage Pharmaceuticals Inc. Revenue in Pseudotumor Cerebri Business (2016-2021)
11.5.5 Heritage Pharmaceuticals Inc. Recent Development
11.6 Ingenus Pharmaceuticals
11.6.1 Ingenus Pharmaceuticals Company Details
11.6.2 Ingenus Pharmaceuticals Business Overview
11.6.3 Ingenus Pharmaceuticals Pseudotumor Cerebri Introduction
11.6.4 Ingenus Pharmaceuticals Revenue in Pseudotumor Cerebri Business (2016-2021)
11.6.5 Ingenus Pharmaceuticals Recent Development
11.7 Integra LifeSciences Corporation
11.7.1 Integra LifeSciences Corporation Company Details
11.7.2 Integra LifeSciences Corporation Business Overview
11.7.3 Integra LifeSciences Corporation Pseudotumor Cerebri Introduction
11.7.4 Integra LifeSciences Corporation Revenue in Pseudotumor Cerebri Business (2016-2021)
11.7.5 Integra LifeSciences Corporation Recent Development
11.8 Johnson & Johnson Services, Inc.
11.8.1 Johnson & Johnson Services, Inc. Company Details
11.8.2 Johnson & Johnson Services, Inc. Business Overview
11.8.3 Johnson & Johnson Services, Inc. Pseudotumor Cerebri Introduction
11.8.4 Johnson & Johnson Services, Inc. Revenue in Pseudotumor Cerebri Business (2016-2021)
11.8.5 Johnson & Johnson Services, Inc. Recent Development
11.9 Lannett Company, Inc.
11.9.1 Lannett Company, Inc. Company Details
11.9.2 Lannett Company, Inc. Business Overview
11.9.3 Lannett Company, Inc. Pseudotumor Cerebri Introduction
11.9.4 Lannett Company, Inc. Revenue in Pseudotumor Cerebri Business (2016-2021)
11.9.5 Lannett Company, Inc. Recent Development
11.10 Magstim
11.10.1 Magstim Company Details
11.10.2 Magstim Business Overview
11.10.3 Magstim Pseudotumor Cerebri Introduction
11.10.4 Magstim Revenue in Pseudotumor Cerebri Business (2016-2021)
11.10.5 Magstim Recent Development
11.11 Medtronic
11.11.1 Medtronic Company Details
11.11.2 Medtronic Business Overview
11.11.3 Medtronic Pseudotumor Cerebri Introduction
11.11.4 Medtronic Revenue in Pseudotumor Cerebri Business (2016-2021)
11.11.5 Medtronic Recent Development
11.12 MercuryPharma
11.12.1 MercuryPharma Company Details
11.12.2 MercuryPharma Business Overview
11.12.3 MercuryPharma Pseudotumor Cerebri Introduction
11.12.4 MercuryPharma Revenue in Pseudotumor Cerebri Business (2016-2021)
11.12.5 MercuryPharma Recent Development
11.13 Nostrum Laboratories Inc.
11.13.1 Nostrum Laboratories Inc. Company Details
11.13.2 Nostrum Laboratories Inc. Business Overview
11.13.3 Nostrum Laboratories Inc. Pseudotumor Cerebri Introduction
11.13.4 Nostrum Laboratories Inc. Revenue in Pseudotumor Cerebri Business (2016-2021)
11.13.5 Nostrum Laboratories Inc. Recent Development
11.14 Novast Holdings Ltd.
11.14.1 Novast Holdings Ltd. Company Details
11.14.2 Novast Holdings Ltd. Business Overview
11.14.3 Novast Holdings Ltd. Pseudotumor Cerebri Introduction
11.14.4 Novast Holdings Ltd. Revenue in Pseudotumor Cerebri Business (2016-2021)
11.14.5 Novast Holdings Ltd. Recent Development
11.15 Phoenix Biomedical Corp.
11.15.1 Phoenix Biomedical Corp. Company Details
11.15.2 Phoenix Biomedical Corp. Business Overview
11.15.3 Phoenix Biomedical Corp. Pseudotumor Cerebri Introduction
11.15.4 Phoenix Biomedical Corp. Revenue in Pseudotumor Cerebri Business (2016-2021)
11.15.5 Phoenix Biomedical Corp. Recent Development
11.16 Sanofi, SGPharma Pvt. Ltd.
11.16.1 Sanofi, SGPharma Pvt. Ltd. Company Details
11.16.2 Sanofi, SGPharma Pvt. Ltd. Business Overview
11.16.3 Sanofi, SGPharma Pvt. Ltd. Pseudotumor Cerebri Introduction
11.16.4 Sanofi, SGPharma Pvt. Ltd. Revenue in Pseudotumor Cerebri Business (2016-2021)
11.16.5 Sanofi, SGPharma Pvt. Ltd. Recent Development
11.17 Sophysa
11.17.1 Sophysa Company Details
11.17.2 Sophysa Business Overview
11.17.3 Sophysa Pseudotumor Cerebri Introduction
11.17.4 Sophysa Revenue in Pseudotumor Cerebri Business (2016-2021)
11.17.5 Sophysa Recent Development
11.18 Taro Pharmaceutical Industries Ltd.
11.18.1 Taro Pharmaceutical Industries Ltd. Company Details
11.18.2 Taro Pharmaceutical Industries Ltd. Business Overview
11.18.3 Taro Pharmaceutical Industries Ltd. Pseudotumor Cerebri Introduction
11.18.4 Taro Pharmaceutical Industries Ltd. Revenue in Pseudotumor Cerebri Business (2016-2021)
11.18.5 Taro Pharmaceutical Industries Ltd. Recent Development
11.18 Teva Pharmaceutical Industries Ltd.
.1 Teva Pharmaceutical Industries Ltd. Company Details
.2 Teva Pharmaceutical Industries Ltd. Business Overview
.3 Teva Pharmaceutical Industries Ltd. Pseudotumor Cerebri Introduction
.4 Teva Pharmaceutical Industries Ltd. Revenue in Pseudotumor Cerebri Business (2016-2021)
.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.20 West-Ward Pharmaceutical
11.20.1 West-Ward Pharmaceutical Company Details
11.20.2 West-Ward Pharmaceutical Business Overview
11.20.3 West-Ward Pharmaceutical Pseudotumor Cerebri Introduction
11.20.4 West-Ward Pharmaceutical Revenue in Pseudotumor Cerebri Business (2016-2021)
11.20.5 West-Ward Pharmaceutical Recent Development
11.21 Zydus Pharmaceuticals, Inc.
11.21.1 Zydus Pharmaceuticals, Inc. Company Details
11.21.2 Zydus Pharmaceuticals, Inc. Business Overview
11.21.3 Zydus Pharmaceuticals, Inc. Pseudotumor Cerebri Introduction
11.21.4 Zydus Pharmaceuticals, Inc. Revenue in Pseudotumor Cerebri Business (2016-2021)
11.21.5 Zydus Pharmaceuticals, Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Pseudotumor Cerebri Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Fundoscopy
Table 3. Key Players of Neuroimaging
Table 4. Key Players of Lumbar Puncture
Table 5. Global Pseudotumor Cerebri Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Pseudotumor Cerebri Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Pseudotumor Cerebri Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Pseudotumor Cerebri Market Share by Regions (2016-2021)
Table 9. Global Pseudotumor Cerebri Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Pseudotumor Cerebri Market Share by Regions (2022-2027)
Table 11. Pseudotumor Cerebri Market Trends
Table 12. Pseudotumor Cerebri Market Drivers
Table 13. Pseudotumor Cerebri Market Challenges
Table 14. Pseudotumor Cerebri Market Restraints
Table 15. Global Pseudotumor Cerebri Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Pseudotumor Cerebri Market Share by Players (2016-2021)
Table 17. Global Top Pseudotumor Cerebri Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pseudotumor Cerebri as of 2020)
Table 18. Ranking of Global Top Pseudotumor Cerebri Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Pseudotumor Cerebri Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Pseudotumor Cerebri Product Solution and Service
Table 22. Date of Enter into Pseudotumor Cerebri Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Pseudotumor Cerebri Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Pseudotumor Cerebri Revenue Market Share by Type (2016-2021)
Table 26. Global Pseudotumor Cerebri Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Pseudotumor Cerebri Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Pseudotumor Cerebri Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Pseudotumor Cerebri Revenue Market Share by Application (2016-2021)
Table 30. Global Pseudotumor Cerebri Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Pseudotumor Cerebri Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Pseudotumor Cerebri Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Pseudotumor Cerebri Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Pseudotumor Cerebri Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Pseudotumor Cerebri Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Pseudotumor Cerebri Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Pseudotumor Cerebri Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Pseudotumor Cerebri Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Pseudotumor Cerebri Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Pseudotumor Cerebri Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Pseudotumor Cerebri Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Pseudotumor Cerebri Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Pseudotumor Cerebri Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Pseudotumor Cerebri Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Pseudotumor Cerebri Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Pseudotumor Cerebri Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Pseudotumor Cerebri Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Pseudotumor Cerebri Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Pseudotumor Cerebri Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Pseudotumor Cerebri Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Pseudotumor Cerebri Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Pseudotumor Cerebri Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Pseudotumor Cerebri Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Pseudotumor Cerebri Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Pseudotumor Cerebri Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Pseudotumor Cerebri Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Pseudotumor Cerebri Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Pseudotumor Cerebri Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Pseudotumor Cerebri Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Pseudotumor Cerebri Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Pseudotumor Cerebri Market Size by Country (2022-2027) & (US$ Million)
Table 62. Avkare, Inc. Company Details
Table 63. Avkare, Inc. Business Overview
Table 64. Avkare, Inc. Pseudotumor Cerebri Product
Table 65. Avkare, Inc. Revenue in Pseudotumor Cerebri Business (2016-2021) & (US$ Million)
Table 66. Avkare, Inc. Recent Development
Table 67. B. Braun Melsungen AG Company Details
Table 68. B. Braun Melsungen AG Business Overview
Table 69. B. Braun Melsungen AG Pseudotumor Cerebri Product
Table 70. B. Braun Melsungen AG Revenue in Pseudotumor Cerebri Business (2016-2021) & (US$ Million)
Table 71. B. Braun Melsungen AG Recent Development
Table 72. Beckersmith Medical, Inc. Company Details
Table 73. Beckersmith Medical, Inc. Business Overview
Table 74. Beckersmith Medical, Inc. Pseudotumor Cerebri Product
Table 75. Beckersmith Medical, Inc. Revenue in Pseudotumor Cerebri Business (2016-2021) & (US$ Million)
Table 76. Beckersmith Medical, Inc. Recent Development
Table 77. Elekta AB Company Details
Table 78. Elekta AB Business Overview
Table 79. Elekta AB Pseudotumor Cerebri Product
Table 80. Elekta AB Revenue in Pseudotumor Cerebri Business (2016-2021) & (US$ Million)
Table 81. Elekta AB Recent Development
Table 82. Heritage Pharmaceuticals Inc. Company Details
Table 83. Heritage Pharmaceuticals Inc. Business Overview
Table 84. Heritage Pharmaceuticals Inc. Pseudotumor Cerebri Product
Table 85. Heritage Pharmaceuticals Inc. Revenue in Pseudotumor Cerebri Business (2016-2021) & (US$ Million)
Table 86. Heritage Pharmaceuticals Inc. Recent Development
Table 87. Ingenus Pharmaceuticals Company Details
Table 88. Ingenus Pharmaceuticals Business Overview
Table 89. Ingenus Pharmaceuticals Pseudotumor Cerebri Product
Table 90. Ingenus Pharmaceuticals Revenue in Pseudotumor Cerebri Business (2016-2021) & (US$ Million)
Table 91. Ingenus Pharmaceuticals Recent Development
Table 92. Integra LifeSciences Corporation Company Details
Table 93. Integra LifeSciences Corporation Business Overview
Table 94. Integra LifeSciences Corporation Pseudotumor Cerebri Product
Table 95. Integra LifeSciences Corporation Revenue in Pseudotumor Cerebri Business (2016-2021) & (US$ Million)
Table 96. Integra LifeSciences Corporation Recent Development
Table 97. Johnson & Johnson Services, Inc. Company Details
Table 98. Johnson & Johnson Services, Inc. Business Overview
Table 99. Johnson & Johnson Services, Inc. Revenue in Pseudotumor Cerebri Business (2016-2021) & (US$ Million)
Table 100. Johnson & Johnson Services, Inc. Recent Development
Table 101. Lannett Company, Inc. Company Details
Table 102. Lannett Company, Inc. Business Overview
Table 103. Lannett Company, Inc. Pseudotumor Cerebri Product
Table 104. Lannett Company, Inc. Revenue in Pseudotumor Cerebri Business (2016-2021) & (US$ Million)
Table 105. Lannett Company, Inc. Recent Development
Table 106. Magstim Company Details
Table 107. Magstim Business Overview
Table 108. Magstim Pseudotumor Cerebri Product
Table 109. Magstim Revenue in Pseudotumor Cerebri Business (2016-2021) & (US$ Million)
Table 110. Magstim Recent Development
Table 111. Medtronic Company Details
Table 112. Medtronic Business Overview
Table 113. Medtronic Pseudotumor Cerebri Product
Table 114. Medtronic Revenue in Pseudotumor Cerebri Business (2016-2021) & (US$ Million)
Table 115. Medtronic Recent Development
Table 116. MercuryPharma Company Details
Table 117. MercuryPharma Business Overview
Table 118. MercuryPharma Pseudotumor Cerebri Product
Table 119. MercuryPharma Revenue in Pseudotumor Cerebri Business (2016-2021) & (US$ Million)
Table 120. MercuryPharma Recent Development
Table 121. Nostrum Laboratories Inc. Company Details
Table 122. Nostrum Laboratories Inc. Business Overview
Table 123. Nostrum Laboratories Inc. Pseudotumor Cerebri Product
Table 124. Nostrum Laboratories Inc. Revenue in Pseudotumor Cerebri Business (2016-2021) & (US$ Million)
Table 125. Nostrum Laboratories Inc. Recent Development
Table 126. Novast Holdings Ltd. Company Details
Table 127. Novast Holdings Ltd. Business Overview
Table 128. Novast Holdings Ltd. Pseudotumor Cerebri Product
Table 129. Novast Holdings Ltd. Revenue in Pseudotumor Cerebri Business (2016-2021) & (US$ Million)
Table 130. Novast Holdings Ltd. Recent Development
Table 131. Phoenix Biomedical Corp. Company Details
Table 132. Phoenix Biomedical Corp. Business Overview
Table 133. Phoenix Biomedical Corp. Pseudotumor Cerebri Product
Table 134. Phoenix Biomedical Corp. Revenue in Pseudotumor Cerebri Business (2016-2021) & (US$ Million)
Table 135. Phoenix Biomedical Corp. Recent Development
Table 136. Sanofi, SGPharma Pvt. Ltd. Company Details
Table 137. Sanofi, SGPharma Pvt. Ltd. Business Overview
Table 138. Sanofi, SGPharma Pvt. Ltd. Pseudotumor Cerebri Product
Table 139. Sanofi, SGPharma Pvt. Ltd. Revenue in Pseudotumor Cerebri Business (2016-2021) & (US$ Million)
Table 140. Sanofi, SGPharma Pvt. Ltd. Recent Development
Table 141. Sophysa Company Details
Table 142. Sophysa Business Overview
Table 143. Sophysa Pseudotumor Cerebri Product
Table 144. Sophysa Revenue in Pseudotumor Cerebri Business (2016-2021) & (US$ Million)
Table 145. Sophysa Recent Development
Table 146. Taro Pharmaceutical Industries Ltd. Company Details
Table 147. Taro Pharmaceutical Industries Ltd. Business Overview
Table 148. Taro Pharmaceutical Industries Ltd. Pseudotumor Cerebri Product
Table 149. Taro Pharmaceutical Industries Ltd. Revenue in Pseudotumor Cerebri Business (2016-2021) & (US$ Million)
Table 150. Taro Pharmaceutical Industries Ltd. Recent Development
Table 151. Teva Pharmaceutical Industries Ltd. Company Details
Table 152. Teva Pharmaceutical Industries Ltd. Business Overview
Table 153. Teva Pharmaceutical Industries Ltd. Pseudotumor Cerebri Product
Table 154. Teva Pharmaceutical Industries Ltd. Revenue in Pseudotumor Cerebri Business (2016-2021) & (US$ Million)
Table 155. Teva Pharmaceutical Industries Ltd. Recent Development
Table 156. West-Ward Pharmaceutical Company Details
Table 157. West-Ward Pharmaceutical Business Overview
Table 158. West-Ward Pharmaceutical Pseudotumor Cerebri Product
Table 159. West-Ward Pharmaceutical Revenue in Pseudotumor Cerebri Business (2016-2021) & (US$ Million)
Table 160. West-Ward Pharmaceutical Recent Development
Table 161. Zydus Pharmaceuticals, Inc. Company Details
Table 162. Zydus Pharmaceuticals, Inc. Business Overview
Table 163. Zydus Pharmaceuticals, Inc. Pseudotumor Cerebri Product
Table 164. Zydus Pharmaceuticals, Inc. Revenue in Pseudotumor Cerebri Business (2016-2021) & (US$ Million)
Table 165. Zydus Pharmaceuticals, Inc. Recent Development
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pseudotumor Cerebri Market Share by Type: 2020 VS 2027
Figure 2. Fundoscopy Features
Figure 3. Neuroimaging Features
Figure 4. Lumbar Puncture Features
Figure 5. Global Pseudotumor Cerebri Market Share by Application: 2020 VS 2027
Figure 6. Spinal Fluid Shunt Case Studies
Figure 7. Optic Nerve Sheath Fenestration Case Studies
Figure 8. Venous Sinus Stenting Case Studies
Figure 9. Medication Case Studies
Figure 10. Pseudotumor Cerebri Report Years Considered
Figure 11. Global Pseudotumor Cerebri Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Pseudotumor Cerebri Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Pseudotumor Cerebri Market Share by Regions: 2020 VS 2027
Figure 14. Global Pseudotumor Cerebri Market Share by Regions (2022-2027)
Figure 15. Global Pseudotumor Cerebri Market Share by Players in 2020
Figure 16. Global Top Pseudotumor Cerebri Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pseudotumor Cerebri as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Pseudotumor Cerebri Revenue in 2020
Figure 18. Global Pseudotumor Cerebri Revenue Market Share by Type (2016-2021)
Figure 19. Global Pseudotumor Cerebri Revenue Market Share by Type (2022-2027)
Figure 20. North America Pseudotumor Cerebri Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Pseudotumor Cerebri Market Share by Type (2016-2027)
Figure 22. North America Pseudotumor Cerebri Market Share by Application (2016-2027)
Figure 23. North America Pseudotumor Cerebri Market Share by Country (2016-2027)
Figure 24. United States Pseudotumor Cerebri Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Pseudotumor Cerebri Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Pseudotumor Cerebri Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Pseudotumor Cerebri Market Share by Type (2016-2027)
Figure 28. Europe Pseudotumor Cerebri Market Share by Application (2016-2027)
Figure 29. Europe Pseudotumor Cerebri Market Share by Country (2016-2027)
Figure 30. Germany Pseudotumor Cerebri Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Pseudotumor Cerebri Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Pseudotumor Cerebri Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Pseudotumor Cerebri Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Pseudotumor Cerebri Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Pseudotumor Cerebri Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Pseudotumor Cerebri Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Pseudotumor Cerebri Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Pseudotumor Cerebri Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Pseudotumor Cerebri Market Share by Region (2016-2027)
Figure 40. China Pseudotumor Cerebri Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Pseudotumor Cerebri Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Pseudotumor Cerebri Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Pseudotumor Cerebri Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Pseudotumor Cerebri Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Pseudotumor Cerebri Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Pseudotumor Cerebri Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Pseudotumor Cerebri Market Share by Type (2016-2027)
Figure 48. Latin America Pseudotumor Cerebri Market Share by Application (2016-2027)
Figure 49. Latin America Pseudotumor Cerebri Market Share by Country (2016-2027)
Figure 50. Mexico Pseudotumor Cerebri Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Pseudotumor Cerebri Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Pseudotumor Cerebri Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Pseudotumor Cerebri Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Pseudotumor Cerebri Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Pseudotumor Cerebri Market Share by Country (2016-2027)
Figure 56. Turkey Pseudotumor Cerebri Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Pseudotumor Cerebri Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Pseudotumor Cerebri Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Avkare, Inc. Revenue Growth Rate in Pseudotumor Cerebri Business (2016-2021)
Figure 60. B. Braun Melsungen AG Revenue Growth Rate in Pseudotumor Cerebri Business (2016-2021)
Figure 61. Beckersmith Medical, Inc. Revenue Growth Rate in Pseudotumor Cerebri Business (2016-2021)
Figure 62. Elekta AB Revenue Growth Rate in Pseudotumor Cerebri Business (2016-2021)
Figure 63. Heritage Pharmaceuticals Inc. Revenue Growth Rate in Pseudotumor Cerebri Business (2016-2021)
Figure 64. Ingenus Pharmaceuticals Revenue Growth Rate in Pseudotumor Cerebri Business (2016-2021)
Figure 65. Integra LifeSciences Corporation Revenue Growth Rate in Pseudotumor Cerebri Business (2016-2021)
Figure 66. Johnson & Johnson Services, Inc. Revenue Growth Rate in Pseudotumor Cerebri Business (2016-2021)
Figure 67. Lannett Company, Inc. Revenue Growth Rate in Pseudotumor Cerebri Business (2016-2021)
Figure 68. Magstim Revenue Growth Rate in Pseudotumor Cerebri Business (2016-2021)
Figure 69. Medtronic Revenue Growth Rate in Pseudotumor Cerebri Business (2016-2021)
Figure 70. MercuryPharma Revenue Growth Rate in Pseudotumor Cerebri Business (2016-2021)
Figure 71. Nostrum Laboratories Inc. Revenue Growth Rate in Pseudotumor Cerebri Business (2016-2021)
Figure 72. Novast Holdings Ltd. Revenue Growth Rate in Pseudotumor Cerebri Business (2016-2021)
Figure 73. Phoenix Biomedical Corp. Revenue Growth Rate in Pseudotumor Cerebri Business (2016-2021)
Figure 74. Sanofi, SGPharma Pvt. Ltd. Revenue Growth Rate in Pseudotumor Cerebri Business (2016-2021)
Figure 75. Sophysa Revenue Growth Rate in Pseudotumor Cerebri Business (2016-2021)
Figure 76. Taro Pharmaceutical Industries Ltd. Revenue Growth Rate in Pseudotumor Cerebri Business (2016-2021)
Figure 77. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Pseudotumor Cerebri Business (2016-2021)
Figure 78. West-Ward Pharmaceutical Revenue Growth Rate in Pseudotumor Cerebri Business (2016-2021)
Figure 79. Zydus Pharmaceuticals, Inc. Revenue Growth Rate in Pseudotumor Cerebri Business (2016-2021)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed

---